Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1995-7-11
pubmed:abstractText
The initiation of Leishmania major infection in susceptible BALB/c mice is regulated by interferon-gamma (IFN-gamma). To examine further the mechanisms of IFN-gamma-dependent regulation of the establishment of L. major, we studied the characteristics of the infection in severe combined immunodeficient (scid) mice. In the first 2 weeks of infection, we observed a delay in the development of the lesions in the footpads and lower numbers of parasites in scid compared with BALB/c mice. By week 5 after infection, the size of the leishmanial lesion was similar in both strains of mice, but the number of parasites in scid mice was 100-fold higher than in BALB/c. Treatment with anti-IFN-gamma during the establishment of L. major did not alter the course of infection in scid mice, while it exacerbated lesion development in BALB/c mice. Macrophages from scid mice were unable to kill L. major when stimulated with IFN-gamma in vitro, and produced lower levels of nitric oxide compared with macrophages from susceptible BALB/c or the resistant C57Bl/6 mice. We examined whether delayed lesion development in scid mice was due to their inability to mount appropriate inflammatory responses. While significantly fewer nucleated cells were present in the footpads of scid mice compared with BALB/c, 2 and 3 weeks after infection, no difference in inflammatory response between scid and BALB/c mice was observed in response to L. major antigen in the footpads. In contrast, there was a dramatic increase in the number of cells in the popliteal lymph nodes of BALB/c mice. Decreased inflammatory responses of scid mice in the footpad (at the site of infection) may contribute to slower development of leishmanial lesions during the first 2 weeks of infection.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-1398944, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-1636090, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-1684779, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-1721024, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-1833466, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-1902195, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-2054113, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-2056250, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-2073318, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-2104918, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-2115543, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-2140583, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-2499625, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-2499629, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-2578226, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-3135315, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-3263720, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-3666964, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-3877902, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-3989296, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-6294182, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-6606002, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-6823332, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-7520472, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-8101861, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-8412622, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-8419179, http://linkedlifedata.com/resource/pubmed/commentcorrection/7774053-8473745
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
100
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
440-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Response of scid mice to establishment of Leishmania major infection.
pubmed:affiliation
Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't